Trial intelligence / Profile preview

Secretome injection of mesenchymal stem cells with erbium laser for facial atrophic scars

IRCT20200127046282N44Phase 2Completed

Sponsor
Tehran University of Medical Sciences
Start
Jun 2024
Modality
Cell Therapies, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 2, single-arm trial of mesenchymal stem cell secretome in atrophic scar, sponsored by Tehran University of Medical Sciences. Started Jun 2024; status: completed.

02

Drugs

mesenchymal stem cell secretome
03

Conditions

atrophic scar

Beyond the preview

Go deeper on IRCT20200127046282N44.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200127046282N44.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call